| scholarly article | Q13442814 |
| P50 | author | Anding Shen | Q67465848 |
| P2093 | author name string | R J Adams | |
| J D Lifson | |||
| M Piatak | |||
| D L Carter | |||
| J E Clements | |||
| J L Mankowski | |||
| M C Zink | |||
| K Suryanarayana | |||
| J P Spelman | |||
| P2860 | cites work | Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection | Q24645815 |
| Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome | Q24648628 | ||
| Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection | Q34740804 | ||
| Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV | Q35763459 | ||
| Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally | Q35852512 | ||
| Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. | Q35861490 | ||
| Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus | Q35889564 | ||
| Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence | Q35890115 | ||
| Neuropathology of Human Immunodeficiency Virus Infection | Q36476918 | ||
| Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques | Q36698054 | ||
| Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques | Q38874696 | ||
| Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus | Q38948757 | ||
| Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons | Q39598890 | ||
| Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. | Q41063277 | ||
| Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia | Q42474669 | ||
| Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction | Q44244285 | ||
| Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia | Q44572012 | ||
| Brain HIV burden and length of survival after AIDS diagnosis | Q44679498 | ||
| Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype | Q45755664 | ||
| Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain | Q45759163 | ||
| Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group | Q45759166 | ||
| Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage | Q45764045 | ||
| Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome | Q45771406 | ||
| Lentivirus-induced Pulmonary Lesions in Rhesus Monkeys (Macaca mulatta) Infected with Simian Immunodeficiency Virus | Q45857232 | ||
| Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization | Q46960543 | ||
| Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis | Q48499698 | ||
| Cognitive and motor impairments associated with SIV infection in rhesus monkeys | Q48509870 | ||
| Serial pathogenesis study of SIV brain infection | Q48711631 | ||
| Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. | Q51993416 | ||
| Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. | Q55487007 | ||
| Sustained cognitive decline in HIV infection: relationship to CD4+ cell count, plasma viremia and p24 antigenemia | Q57446076 | ||
| Human immunodeficiency virus and the central nervous system | Q67587480 | ||
| HIV infection of the central nervous system is characterized by rapid turnover of viral RNA in cerebrospinal fluid | Q74605060 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cerebrospinal fluid | Q54196 |
| Simian immunodeficiency virus | Q1890246 | ||
| viral load | Q2528140 | ||
| P304 | page(s) | 10480-10488 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis | |
| P478 | volume | 73 |
| Q59353529 | A Quantitative Approach to SIV Functional Latency in Brain Macrophages |
| Q40090693 | A SIV molecular clone that targets the CNS and induces neuroAIDS in rhesus macaques. |
| Q36989920 | A plasma microRNA signature of acute lentiviral infection: biomarkers of central nervous system disease |
| Q37829628 | A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system |
| Q34990151 | A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy |
| Q41924980 | An SIV/macaque model targeted to study HIV-associated neurocognitive disorders. |
| Q26767476 | Animal Models for HIV Cure Research |
| Q38248592 | Animal models of HIV peripheral neuropathy |
| Q37592018 | Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system |
| Q27342233 | Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline |
| Q40082046 | Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir |
| Q42227332 | CCR5 inhibition prevents cardiac dysfunction in the SIV/macaque model of HIV. |
| Q40441954 | CD4-independent entry and replication of simian immunodeficiency virus in primary rhesus macaque astrocytes are regulated by the transmembrane protein |
| Q33481045 | Cell-specific temporal infection of the brain in a simian immunodeficiency virus model of human immunodeficiency virus encephalitis |
| Q45722309 | Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection |
| Q40148493 | Central nervous system-specific consequences of simian immunodeficiency virus Gag escape from major histocompatibility complex class I-mediated control |
| Q36913222 | Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis. |
| Q35195923 | Cerebrospinal fluid is an efficient route for establishing brain infection with feline immunodeficiency virus and transfering infectious virus to the periphery |
| Q34594600 | Characterization of simian immunodeficiency virus (SIV) that induces SIV encephalitis in rhesus macaques with high frequency: role of TRIM5 and major histocompatibility complex genotypes and early entry to the brain |
| Q37542200 | Chronic Binge Alcohol Administration Dysregulates Hippocampal Genes Involved in Immunity and Neurogenesis in Simian Immunodeficiency Virus-Infected Macaques |
| Q34714277 | Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease |
| Q26825814 | Considerations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategies |
| Q33519523 | Coordinated regulation of SIV replication and immune responses in the CNS. |
| Q30478136 | Correlation of acute humoral response with brain virus burden and survival time in pig-tailed macaques infected with the neurovirulent simian immunodeficiency virus SIVsmmFGb |
| Q42445800 | Decreased neurotropism of nef long terminal repeat (nef/LTR)-deleted simian immunodeficiency virus |
| Q35003533 | Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins. |
| Q37513129 | Distinct Patterns of Tryptophan Maintenance in Tissues during Kynurenine Pathway Activation in Simian Immunodeficiency Virus-Infected Macaques |
| Q35149650 | Dynamics of viral and proviral loads of feline immunodeficiency virus within the feline central nervous system during the acute phase following intravenous infection |
| Q35083375 | Dysregulation of mitogen-activated protein kinase signaling pathways in simian immunodeficiency virus encephalitis |
| Q34404828 | Early emergence and selection of a SIV-LTR C/EBP site variant in SIV-infected macaques that increases virus infectivity |
| Q35965672 | Early minocycline treatment prevents a decrease in striatal dopamine in an SIV model of HIV-associated neurological disease |
| Q35731648 | Editorial NeuroAIDS review |
| Q28246676 | Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis |
| Q34141266 | Elevated brain monoamine oxidase activity in SIV- and HIV-associated neurological disease |
| Q44315571 | Elevated peripheral benzodiazepine receptor expression in simian immunodeficiency virus encephalitis |
| Q35912988 | Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection |
| Q35020221 | Expression of simian immunodeficiency virus (SIV) nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro |
| Q38572329 | Foxp3 and Treg cells in HIV-1 infection and immuno-pathogenesis |
| Q45735916 | Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus |
| Q33716348 | Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. |
| Q39031641 | Genetic diversity and proviral DNA load in different neural compartments of HIV-1 subtype C infection |
| Q40404098 | HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation. |
| Q40432133 | HIV and HIV dementia |
| Q33882450 | HIV and SIV induce alterations in CNS CaMKII expression and activation: a potential mechanism for cognitive impairment. |
| Q47563715 | HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency |
| Q26766448 | HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment |
| Q36890075 | High frequency of virus-specific CD8+ T cells in the central nervous system of macaques chronically infected with simian immunodeficiency virus SIVmac251. |
| Q24594703 | Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism |
| Q36203752 | Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant? |
| Q35857699 | Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes |
| Q35112016 | Human immunodeficiency virus-associated dementia: an evolving disease |
| Q35104668 | Hydrogen bonding at a conserved threonine in lentivirus capsid is required for virus replication |
| Q39615794 | Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques. |
| Q37727880 | Immune Responses in the Central Nervous System Are Anatomically Segregated in a Non-Human Primate Model of Human Immunodeficiency Virus Infection |
| Q35188470 | Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5. |
| Q92225778 | Infectious Virus Persists in CD4+ T Cells and Macrophages in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected Macaques |
| Q41130300 | Initiation of HAART during acute simian immunodeficiency virus infection rapidly controls virus replication in the CNS by enhancing immune activity and preserving protective immune responses |
| Q43984822 | Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system |
| Q34434339 | Is the central nervous system a reservoir of HIV-1? |
| Q34755001 | Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility |
| Q34590964 | Longitudinal analysis of monocyte/macrophage infection in simian immunodeficiency virus-infected, CD8+ T-cell-depleted macaques that develop lentiviral encephalitis |
| Q36691098 | Longitudinal in vivo positron emission tomography imaging of infected and activated brain macrophages in a macaque model of human immunodeficiency virus encephalitis correlates with central and peripheral markers of encephalitis and areas of synapti |
| Q37661792 | Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation |
| Q47566977 | Lymphocyte-Dominant Encephalitis and Meningitis in Simian Immunodeficiency Virus-Infected Macaques Receiving Antiretroviral Therapy |
| Q41489433 | Macaque species susceptibility to simian immunodeficiency virus: increased incidence of SIV central nervous system disease in pigtailed macaques versus rhesus macaques |
| Q33840048 | Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues |
| Q35474314 | Macrophage-mediated dorsal root ganglion damage precedes altered nerve conduction in SIV-infected macaques |
| Q37182704 | Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections |
| Q32066108 | Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis |
| Q34893901 | Measles viral load may reflect SSPE disease progression |
| Q37064542 | Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1. |
| Q37968178 | Monocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans |
| Q35634100 | Multiplexed Component Analysis to Identify Genes Contributing to the Immune Response during Acute SIV Infection |
| Q24647731 | Natural host genetic resistance to lentiviral CNS disease: a neuroprotective MHC class I allele in SIV-infected macaques |
| Q35177355 | Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS. |
| Q34734802 | Neuroinflammation and virus replication in the spinal cord of simian immunodeficiency virus-infected macaques |
| Q35886296 | Neuropathology of wild-type and nef-attenuated T cell tropic simian immunodeficiency virus (SIVmac32H) and macrophage tropic neurovirulent SIVmac17E-Fr in cynomolgus macaques |
| Q42268235 | Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brain |
| Q36597909 | Neuropsychological test performance before and after HIV-1 seroconversion: the Multicenter AIDS Cohort Study |
| Q44195653 | Neurovirulence depends on virus input titer in brain in feline immunodeficiency virus infection: evidence for activation of innate immunity and neuronal injury |
| Q38932858 | Non-human primate models of SIV infection and CNS neuropathology |
| Q37264017 | Nonhuman primate models of NeuroAIDS |
| Q26852969 | Paving the path to HIV neurotherapy: Predicting SIV CNS disease |
| Q36167247 | Persistent Peripheral Nervous System Damage in Simian Immunodeficiency Virus-Infected Macaques Receiving Antiretroviral Therapy |
| Q45418066 | Platelet decline: an early predictive hematologic marker of simian immunodeficiency virus central nervous system disease |
| Q34162407 | PrPC, the Cellular Isoform of the Human Prion Protein, Is a Novel Biomarker of HIV-Associated Neurocognitive Impairment and Mediates Neuroinflammation |
| Q33580220 | Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS |
| Q40734962 | Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques |
| Q27307670 | Quantitation of gene expression in formaldehyde-fixed and fluorescence-activated sorted cells |
| Q35883306 | Quinolinic acid/tryptophan ratios predict neurological disease in SIV-infected macaques and remain elevated in the brain under cART. |
| Q37284227 | RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system disease |
| Q33593821 | Regulation of SIV mac 239 basal long terminal repeat activity and viral replication in macrophages: functional roles of two CCAAT/enhancer-binding protein beta sites in activation and interferon beta-mediated suppression |
| Q38886489 | Role of microglial cells in selective replication of simian immunodeficiency virus genotypes in the brain |
| Q37175209 | Roles of MCP-1 in development of HIV-dementia |
| Q36645459 | SAMHD1 transcript upregulation during SIV infection of the central nervous system does not associate with reduced viral load. |
| Q54209057 | SIV Latency in Macrophages in the CNS. |
| Q37155048 | SIV replication is directly downregulated by four antiviral miRNAs. |
| Q90003262 | SIV-Induced Immune Activation and Metabolic Alterations in the Dorsal Root Ganglia During Acute Infection |
| Q35242182 | SIV/macaque model of HIV infection in cocaine users: minimal effects of cocaine on behavior, virus replication, and CNS inflammation |
| Q45409291 | Sequence variation in the CC-chemokine ligand 2 promoter of pigtailed macaques is not associated with the incidence or severity of neuropathology in a simian immunodeficiency virus model of human immunodeficiency virus central nervous system disease |
| Q36315704 | Severe depletion of CD4+ CD25+ regulatory T cells from the intestinal lamina propria but not peripheral blood or lymph nodes during acute simian immunodeficiency virus infection |
| Q42716884 | Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection |
| Q33850643 | Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease |
| Q33893665 | Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA |
| Q41873622 | Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection |
| Q37605089 | Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages |
| Q36594100 | Systemic and brain macrophage infections in relation to the development of simian immunodeficiency virus encephalitis |
| Q36991469 | The ART of HIV therapies: dopaminergic deficits and future treatments for HIV pediatric encephalopathy |
| Q37264024 | The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: from mechanism to treatment |
| Q45434391 | The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy |
| Q37781306 | Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction |
| Q37646891 | Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques |
| Q36515464 | Tissue-specific interferon alpha subtype response to SIV infection in brain, spleen, and lung |
| Q42114039 | Transmigration of macrophages across the choroid plexus epithelium in response to the feline immunodeficiency virus |
| Q37153550 | Tristetraprolin expression and microRNA-mediated regulation during simian immunodeficiency virus infection of the central nervous system |
| Q35857688 | Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS. |
| Q37264013 | Virus-host interaction in the simian immunodeficiency virus-infected brain |
| Q33343967 | YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor |
Search more.